ASKLEPIOS Maintains Strong Performance Despite Industry Challenges

Asklepios Kliniken has reported a positive operational performance for H1 2026. The company treated 2,086,056 patients, marking an 8.0% rise from the previous year. Inpatient cases increased by 4.5% and outpatient by 8.9%, indicating strong growth in both sectors.

The group's revenue reached EUR 3,297.8 million, a 4.8% increase from the previous year, and EBITDA grew 8.1% to EUR 323.4 million, enhancing the EBITDA margin to 9.8%. Consolidated earnings after tax rose from EUR 86.3 million to EUR 90.2 million, maintaining the EAT margin at 2.7%.

Challenges remain for the German hospital sector amid inflation, rising costs, and regulatory changes. Hospital reform and hybrid DRGs are reshaping care delivery. Despite these changes, Asklepios has adjusted strategically with targeted investments and digitalization, confirming moderate revenue growth for 2026.